explore -WSS

explore

author：Wikipedia 2025-10-01 11:45:29 - browse：5

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Change Healthcare cyberattack outage could last weeks

Wikipedia

WSS

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Dementia risk linked to living in disadvantaged areas: Study

Clinical trials giant ICON acquires HumanFirst

Caribou posts encouraging results on off

The stock market has soared this year, but will it last? Experts weigh in

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Wikipedia

explore

explore

Medicare details structure of new drug price negotiation program

'CMA Fest' 2023: How to watch, who is performing and more

23andMe had bad news about my health. I wish a person had delivered it

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

At least 13 dead in Texas as scorching temps continue

After a decade, new Gardasil ad campaign gets it (mostly) right

New air purifier tech could be key to improving indoor air quality

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

The high cost of giving birth even with insurance

There’s a way to spot data fakery. All journals should be using it

hotspot

Clinical trials giant ICON acquires HumanFirst

FogPharma raises $145 million in rare Series E round

Medical device lobby: We're tired of waiting on Medicare coverage

Delta passengers in Vegas fall sick while waiting on flight in triple

A Q&A with Aletha Maybank, AMA’s chief health equity officer

RaDonda Vaught to speak at CommonSpirit event on patient safety

explore

explore

Wikipedia

hotspot